Robert F Kucharik

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Vela Pharmaceuticals, Inc., Vela Acquisition Corporation. Active years: 2003-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert F Kucharik. Retrieved from https://idiyas.com/inventor/robert-f-kucharik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 28.6

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 1

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

6 out of 9

Vela Pharmaceuticals, Inc.

patents

1 out of 2

Vela Acquisition Corporation

patents

Years Active: 2003-2010

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7745431 - Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof (2010-06-29),

2. 7078398 - Compositions and methods for treating or preventing convulsions or seizures (2006-07-18),

3. 7022700 - Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines (2006-04-04),

4. 6864251 - Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines (2005-03-08),

5. 6683072 - Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia (2004-01-27),

6. 6649607 - Compositions and methods for treating or preventing convulsions or seizures (2003-11-18),

7. 6638928 - Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines (2003-10-28),

Title: The Innovations of Robert F Kucharik

Introduction

Robert F Kucharik is a notable inventor based in Glenmoore, PA (US), recognized for his contributions to the pharmaceutical field. He holds a total of seven patents, showcasing his innovative spirit and dedication to advancing medical science. His work primarily focuses on pharmaceutical compositions that address various health disorders.

Latest Patents

Kucharik's latest patents include a pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and its uses. These compositions are designed for treating, preventing, or delaying the onset of disorders mediated by LTB, TXA, or adenosine. Another significant patent involves compositions and methods for treating or preventing convulsions or seizures. This invention relates to compositions comprising S-tofisopam, which is substantially free of R-tofisopam, and methods for administering this composition to individuals in need of treatment.

Career Highlights

Throughout his career, Kucharik has worked with various companies, including Vela Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His patents reflect a commitment to improving patient outcomes through effective treatments.

Collaborations

Kucharik has collaborated with notable professionals in the field, including Herbert W Harris and Steven M Leventer. These partnerships have contributed to the development of his innovative pharmaceutical compositions.

Conclusion

Robert F Kucharik's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the field positively, providing valuable solutions for treating various medical conditions.

Profile summary based on public USPTO records.